NO2433629T3 - - Google Patents

Info

Publication number
NO2433629T3
NO2433629T3 NO10178222A NO10178222A NO2433629T3 NO 2433629 T3 NO2433629 T3 NO 2433629T3 NO 10178222 A NO10178222 A NO 10178222A NO 10178222 A NO10178222 A NO 10178222A NO 2433629 T3 NO2433629 T3 NO 2433629T3
Authority
NO
Norway
Application number
NO10178222A
Other languages
Norwegian (no)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of NO2433629T3 publication Critical patent/NO2433629T3/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
NO10178222A 2010-09-22 2010-09-22 NO2433629T3 (en14)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP10178222.5A EP2433629B1 (en) 2010-09-22 2010-09-22 Use of boswellic acids for the prophylaxis and/or treatment of damages and/or inflammation of the islets of Langerhans

Publications (1)

Publication Number Publication Date
NO2433629T3 true NO2433629T3 (en14) 2018-04-07

Family

ID=43061397

Family Applications (1)

Application Number Title Priority Date Filing Date
NO10178222A NO2433629T3 (en14) 2010-09-22 2010-09-22

Country Status (7)

Country Link
US (1) US8975228B2 (en14)
EP (2) EP2433629B1 (en14)
JP (1) JP5952821B2 (en14)
ES (1) ES2655885T3 (en14)
NO (1) NO2433629T3 (en14)
PL (1) PL2433629T3 (en14)
WO (1) WO2012038251A1 (en14)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE537397C2 (sv) 2013-06-28 2015-04-21 Alelion Batteries Ab Batterianordning för eldrivna industrifordon
US9975917B1 (en) 2017-09-20 2018-05-22 King Saud University Pentacyclic triterpenoidal derivatives
GB2581318A (en) * 2018-11-26 2020-08-19 Adrian John Jackson Adam Novel compositions
CN110169971A (zh) * 2019-04-18 2019-08-27 天津中医药大学 一种包含3乙酰-α、β乳香酸的药物及其在预防、治疗胰腺炎中的应用
CN115414366B (zh) * 2022-08-23 2023-11-03 武汉科前生物股份有限公司 11-酮基-beta-乳香酸在制备治疗猫杯状病毒病的药物中的应用

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU4450600A (en) * 1999-04-30 2000-11-17 Sabinsa Corporation Compositions of boswellic acids derived from boswellia serrata gum resin, for treating lymphoproliferative and autoimmune conditions
US20020102231A1 (en) * 1999-05-07 2002-08-01 Icos Corporation Therapeutic uses of PAF-AH products in diabetes
AU2001261409A1 (en) 2000-05-11 2001-11-20 Oklahoma Medical Research Foundation Prevention of insulin-dependent diabetes, complications thereof, or allograft rejection by inhibition of cyclooxygenase-2 activity with NS398 or PDTC
DE10035591A1 (de) * 2000-07-21 2002-01-31 Hasan Safayhi Verfahren zur Isolierung von tetra-und pentacyclischen Triterpensäuren
US20060148732A1 (en) * 2000-11-17 2006-07-06 Gutterman Jordan U Inhibition of NF-kappaB by triterpene compositions
AU2003220240A1 (en) * 2002-03-13 2003-09-29 Biophysica, Inc. Boswellin compositions enhanced with 3-beta-acety1-11-keto-beta-boswellic acid (akba), industrial manufacture and their uses
US20050282772A1 (en) * 2004-06-21 2005-12-22 Gokaraju Ganga R New dietary supplement composition for obesity and inflammation
JP2009506044A (ja) * 2005-08-23 2009-02-12 アクセス ビジネス グループ インターナショナル リミテッド ライアビリティ カンパニー サイトカインの調節物質及び関連する使用方法
US20070048246A1 (en) * 2005-09-01 2007-03-01 Biophysica Research, Inc. Novel skin care compositions
JP2007326839A (ja) * 2006-06-06 2007-12-20 Waccord:Kk 糖尿病、歯周病および関節炎の改善を目的とする健康食品
WO2008065666A2 (en) * 2006-11-29 2008-06-05 Yissum Research Development Company Of The Hebrew University Of Jerusalem, Ltd. Uses of incensole, incensole acetate and derivatives thereof
JP5715952B2 (ja) * 2008-09-15 2015-05-13 ライラ ニュートラシューティカルズ ボスウェリア・セラータエキスを含む相乗作用性抗炎症組成物

Also Published As

Publication number Publication date
PL2433629T3 (pl) 2018-04-30
US20120070497A1 (en) 2012-03-22
JP2013537894A (ja) 2013-10-07
JP5952821B2 (ja) 2016-07-13
EP3338773A1 (en) 2018-06-27
WO2012038251A1 (en) 2012-03-29
ES2655885T3 (es) 2018-02-22
US8975228B2 (en) 2015-03-10
EP2433629B1 (en) 2017-11-08
EP2433629A1 (en) 2012-03-28

Similar Documents

Publication Publication Date Title
BR122017007260A2 (en14)
BR112013013385A2 (en14)
BR112013008959A2 (en14)
BR112012031500A2 (en14)
BR112012019354A2 (en14)
BR112012002126A2 (en14)
BR112012017960A2 (en14)
BR112013006400A2 (en14)
BR112012031826A2 (en14)
BR112012016456A2 (en14)
BR112012018256A2 (en14)
BR112012023265A2 (en14)
BR112013010949A2 (en14)
BR112012022788A2 (en14)
BR112013012726A2 (en14)
BR112013003284A2 (en14)
BR112013002646A2 (en14)
BR112013006825A2 (en14)
BR112012016895A2 (en14)
BR112013007728A2 (en14)
BR122017023123A2 (en14)
BR112013015388A2 (en14)
NO2433629T3 (en14)
BR112013007731A2 (en14)
BR112012019465A2 (en14)